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The  geno-  and  cytotoxicity  of  gold
nanoparticles  in  cancer  and healthy
cells  were  investigated.
The  reactive  oxygen  species  (ROS)
generation  was  evidenced  for  both
cells.
The  healthy  cells  exhibit  less  sensi-
tive  to DNA  damage  than  cancer  cells.
The  nanoparticulate  systems  can
be  applied  in  cancer  therapy  with
reduced  side  effects.
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a  b  s  t  r  a  c  t
Engineered  nanomaterials  have  been  extensively  applied  as  active  materials  for technological  applica-
tions.  Since  the impact  of these  nanomaterials  on health  and  environment  remains  undeﬁned,  research  on
their  possible  toxic  effects  has  attracted  considerable  attention.  It  is  known  that in  humans,  for  example,
the  primary  site of gold  nanoparticles  (AuNps)  accumulation  is  the  liver.  The  latter  has  motivated  research
regarding  the  use  of AuNps  for cancer  therapy,  since  speciﬁc  organs  can  be  target upon  appropriate  func-
tionalization  of  speciﬁc  nanoparticles.  In this  study,  we  investigate  the  geno  and  cytotoxicity  of two  types
of  AuNps  against  human  hepatocellular  carcinoma  cells  (HepG2)  and  peripheral  blood  mononuclear  cellseywords:
anotoxicity
anomedicine
uman hepatocarcinoma cell
uman peripheral blood mononuclear cells
omet assay
(PBMC)  from  healthy  human  volunteers.  The  cells  were  incubated  in the  presence  of different  concentra-
tions  of  AuNps  capped  with  either  sodium  citrate  or polyamidoamine  dendrimers  (PAMAM).  Our results
suggest  that both  types  of  AuNps  interact  with  HepG2  cells  and  PBMC  and  may  exhibit in  vitro  geno  and
cytotoxicity  even  at very  low  concentrations.  In addition,  the  PBMC  were  less  sensitive  to  DNA  damage
toxicity  effects  than  cancer  HepG2  cells  upon  exposure  to  AuNps.ytotoxicity
. IntroductionMetallic nanoparticles have attracted enormous scientiﬁc and
echnological interest, mainly due to their unique, size dependent
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properties that allow their use as active materials in food, cos-
metic, clothing, and biomedical areas (Kreuter and Gelperina, 2008;
Johnston et al., 2010). Gold nanoparticles (AuNps), in particular,
have been extensively designed and applied in biomedicine, espe-
cially for drug delivery, molecular imaging and cancer therapy
(Alkilany and Murphy, 2010; Lewinski et al., 2008). As example, a
new chemotherapy strategy has been proposed by Tomuleasa et al.
Open access under the Elsevier OA license.(2012) regarding the use of AuNps conjugated with conventional
chemotherapy drugs. The authors observed that the proliferation
of hepatocellular carcinoma cancer cells was  lower for cultures
exposed to AuNps/chemotherapy drugs conjugates, in comparison
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o cultures exposed to isolated cytostatic drugs (Tomuleasa et al.,
012).
Due to their possible use in biomedical areas, AuNps have been
ubject of research regarding the potential risks related to human
xposure, upon investigating their interaction with biomolecules,
ells and tissues (Maurer-Jones et al., 2009). Small AuNps (1 nm
n diameter) can easily cross the cell membrane and nucleus, and
ttach to the DNA (Tsoli et al., 2005). A study by Thakor et al.
2011) showed that the treatment with AuNps in HeLa or HepG2
ell lines caused no cytotoxicity at lower concentrations; how-
ver, cytotoxicity was observed at higher AuNps concentrations,
fter prolonged, continuous exposure to AuNps, in both cell lines.
ernodet et al. (2006) also demonstrated that citrate-coated AuNps
ffected human dermal ﬁbroblast cell lines. On the other hand, a
tudy by Connor et al. (2005) reported that 18 nm-diameter AuNps
xhibited signiﬁcant penetration into cells, but surprisingly, cyto-
oxicity was not observed.
The  human hepatoma (HepG2) cells have been chosen as exper-
mental models for in vitro toxicological studies (Wei  et al., 2007)
ainly because in vivo studies have demonstrated that the pri-
ary site of AuNps accumulation is the liver (Ogawara et al., 1999;
chipper et al., 2009; Sonavane et al., 2008). The latter has been
lso reported by Johnston et al. (2010), who demonstrated that the
ptake of 20 nm polystyrene nanoparticles by primary rat hepato-
ytes and human hepatocyte cell lines (C3A and HepG2) was size
nd time dependent.
Several  studies have also investigated the genotoxic potential of
anoparticles upon examining the extent of DNA damage using the
omet assay (Collins, 2004). This methodology has become one of
he standard methods for assessing DNA damage, with applications
n nanotoxicology. The alkaline version of comet assay is one of the
ost important tools in a wide variety of cell lines for evaluation ofape of a cluster of PAMAM (a) and citrate coated AuNps (b).
genotoxicity or DNA damage, upon calculating the DNA migration
(Piperakis, 2009).
Since  scarce studies have reported the effects of AuNps on
HepG2 cells, especially on human cells from the immune sys-
tem, the objective of this paper is to investigate the cyto and
genotoxicity of AuNps stabilized with polyamidoamine (PAMAM)
dendrimer and sodium citrate against HepG2 cells and Peripheral
Blood Mononuclear Cells (PBMC) from healthy human volunteers.
Our ﬁndings may  reduce the serious lack of information and contro-
versial studies concerning the toxicological effects of engineering
gold nanoparticles.
2. Materials and methods
2.1.  Materials synthesis and characterization of AuNps
Chemicals were obtained from Sigma–Aldrich (USA). Glutamine, peni-
cillin/streptomycin, fetal bovine serum, cell culture media were purchased from
Cultilab (Brazil). Doxorubicin (DXR) was  used in commercial formula: Adriblastin1
RD  (CAS: 25316-40-9, Pharmacia and Upjohn, Milan, Italy).
AuNps  were chemically synthesized in the presence of PAMAM or sodium
citrate,  leading to the formation of AuNps with diameters ranging from 7 to 20 nm,
bearing positive and negative charges, respectively. Details on the synthesis of the
Nps-PAMAM can be found elsewhere (Crespilho et al., 2007). Brieﬂy, 2 mL  of PAMAM
G4 (0.07 mmol  L−1) were added to 2 mL  of HAuCl4 solution (1 mmol L−1) and 2 mL
of  formic acid 10% (v/v). This solution was mixed and shaked during 4 h. The color
changed from yellow to red, indicating the zerovalent Au complex was formed after
4 h.
The  AuNps-citrate were obtained by citrate reduction of gold salts, as pre-
viously  described (Grabar et al., 1995). Brieﬂy, 1.0 mL  of 1% sodium citrate was
added  to 14 mL  of boiling solution 0.5 mmol L−1 HAuCl4 with vigorous stirring. The
ﬁnal  solution color changes to red–violet rapidly. The nanoparticle formation was
monitored by UV–vis spectrophotometry (Hitachi U-2001 Spectrophotometer; San
Jose, CA, USA). AuNPs morphology and particle size distribution were estimated by
transmission electron microscopy (TEM, Model CM200; Philips, the Netherlands)
by  measuring at least 100 particles in TEM images using the program Image J
I.M.M. Paino et al. / Toxicology Letters 215 (2012) 119– 125 121
Table  1
Zeta  potential and hydrodynamic diameter values of PAMAM and citrate-covered AuNps before and after dilution in cell culture medium supplemented with 10% FBS.
AuNp-citrate AuNp-PAMAM
Zeta potential (mV) as prepared −15.0 ± 3.0 +41.0 ± 3.0
Zeta potential (mV) in medium cell culture containing 10% FBS −1.2 ± 0.3 −6.8 ± 0.5
Hydrodynamic diameter (nm) as prepared 7.3 ± 1.2 7.2 ± 2.7
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ata are reported as means ± standard deviation (SD) of triplicate experiments.
Java-Sun  Microsystems). Typical AuNPs TEM images used in this study are shown in
ig. 1. The Zeta potential and the hydrodynamic diameter were measured (Malvern
etasizer)  before and after AuNp dilution into cell culture medium with serum (10%
etal bovine serum-FBS) (Table 1).
The citrate or PAMAM excess was removed upon successive centrifugation and
insing steps using phosphate buffer saline 0.05 M (PBS) solution. After each cen-
rifugation, the AuNps were resuspended in 0.05 M PBS at pH 7.0 following the
iscard of the supernatant. The process was repeated three times to eliminate
he  free citrate or PAMAM molecules. The AuNps were then diluted in cell culture
edium.  Finally, the AuNps were sonicated for 30 min  before using.
.2. Isolation of human peripheral blood mononuclear cell (PBMC)
Whole  peripheral blood was collected from women and men adult healthy
olunteers,  no tobacco users, no pregnant women. They were informed about the
xperimental procedures, signed consent form to participate in the study, and all
he procedures were approved by the Ethics Committee of the Federal University of
ão Carlos in keeping with the principles enunciated in the Declaration of Helsinki.
ll  subjects were not taking any type of medication. The PBMC isolation was made
y the difference of gradient density Ficoll-Hypaque (Histopaque® , Sigma–Aldrich-
SA)  1077. After centrifugation (400 × g; 30 min  at room temperature), the PBMC
ere  found at the plasma/1077 interphase and collected carefully with a Pasteur
ipette.  After that, the cells were washed in PBS twice (240 × g for 10 min), and
esuspended  in RPMI 1640 medium containing 4.5 g/L glucose supplemented with
 mM l-glutamine, penicillin/streptomycin (50 IU/mL and 50 g/mL, respectively)
nd  10% (v/v) fetal bovine serum (FBS).
.3. Cell culture and incubation
The  human hepatocellular carcinoma (HepG2) cells from the American Type
ulture  Collection (ATCC) were subcultured in a 75 cm2 ﬂasks in Dulbecco’s
odiﬁed  Eagle’s medium (DMEM) supplemented with 2 mM l-glutamine, peni-
illin/streptomycin (50 IU/mL and 50 g/mL, respectively) and 10% (v/v) FBS. HepG2
ells and PBMC were maintained at 37 ◦C in a 5% CO2/air incubator (Thermo Electron
o.)  and veriﬁed in an inverted microscope (Nikon Eclipse Ti, Japan). To analyze the
ytotoxicity effects of AuNps, HepG2 cells and PBMC were incubated with AuNps-
itrate  and AuNps-PAMAM. Control experiments containing only PAMAM in the
ulture medium have also been performed. Cytotoxicity was  investigated using
he 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay.
he genotoxicity was  measured by the alkaline comet assay. Viability of the cells
xposed to AuNps was  also determined by the trypan blue exclusion assay, imme-
iately before all the assays (Freshney, 2000). In a viable cell, trypan blue dye
Sigma–Aldrich,  USA) is not absorbed. The number of viable cells was  always >90%
or each cell suspension in both control and treated groups before the assays.
.4. Cytotoxicity assay
Cytotoxicity was  also determinated using MTT  assay (Mosmann, 1983), a
ethod  for determining cell viability by measuring the mitochondrial dehydroge-
ase  action. This enzyme reduces MTT  to water-insoluble blue formazan crystals.
ells  were counted and plated (1 × 105 cells/well) in 96-well culture plates and
llowed  to adhere (HepG2) or stabilization (PBMC) at 37 ◦C in a 5% CO2 atmosphere
or  24 h. The freshly prepared AuNps-PAMAM and AuNps-citrate were dispersed
n  cell culture medium, diluted at concentrations from 0.01 to 50.0 M and were
dded  to each culture well. Doxorubicin (DXR) was used as the positive control and
nalyzed at the concentration of 0.3 M.  DXR is an antitumor agent that acts by
ntercalating  the DNA. It is rapidly taken up into the nucleus of cells, inhibiting DNA
ynthesis, binding with high afﬁnity to DNA by classical intercalation between base
airs, promoting single strand breaks in DNA and inhibiting DNA topoisomerase II
Cutts et al., 2005). A negative control containing only cells in culture medium was
lso evaluated. After 24 h of treatment, the plates were incubated with 10 L of MTT
Sigma–Aldrich, USA) solution (0.5 mg/mL) for 4 h at 37 ◦C in a 5% CO2 atmosphere.
he  plate was  centrifuged at 1500 rpm for 10 min. The medium was removed and
eplaced by 100 L of dimethyl sulfoxide (DMSO), followed by mixing to dissolve
he  formazan crystals. Absorbance was measured at 570 nm on a microenzyme-
inked  immunosorbent assay (ELISA) reader (Spectramax, Molecular Devices®) and
he reduction of cell viability was expressed as the percentage compared with the
egative control group designated as 100%. A control experiment carried out using
nly PAMAM in the culture medium did not induced cytotoxicity (data not shown).10.1 ± 0.3 12.1 ± 3.3
2.5.  DNA damage assay
Nanoparticle-induced DNA damage was performed by the comet assay (also
referred  to as the single-cell gel electrophoresis – SCGE analysis) under alkaline
conditions  (Singh et al., 1988). The negative control was exposed without AuNps
under  the same conditions. HepG2 cells and PBMC were cultured in 12-well cul-
ture plates as described above, and then pretreated for 3 h with 1.0 and 50.0 M
of AuNps-citrate and AuNps-PAMAM. Microscope slides were prepared in dupli-
cate and coated with 1% normal melting point agarose (NMA). 60 L of each cell
suspension  with 300 L of low melting point agarose 1% (LMPA) were placed on
these microscope slides containing NMA, deposited over the agarose layer. Cover-
slips were placed on the gels, which were left to set on ice. After gently removing
the  coverslips, the slides were immediately submersed in cold lysis solution (2.5 M
NaCl, 100 mM EDTA, 10 mM Tris, 1% Tritron X-100, pH 10) for 12 h in the dark.
DNA was  then allowed to unwind for 20 min  in alkaline electrophoresis solution
(300  mM NaOH, 1 mM EDTA, pH > 13). Electrophoresis was performed under 25 V
and 300 mA  for 20 min. Subsequently, the slides were placed in a cold neutralizing
buffer  (400 mM Tris buffer, pH 7.5) for 15 min, dried in 100% methanol for 5 min, and
stained with 50 L of 20 g/mL ethidium bromide in the dark. At least 50 comets per
slide were analyzed under a ﬂuorescence microscope (Nikon Eclipse E200, Japan)
equipped with an excitation ﬁlter of 515–560 nm and a barrier ﬁlter of 590 nm,
connected  to a digital camera (Nikon DS Qi1, Japan). The classical visual analysis
scoring  of the comet assay was analyzed by a single analyst, in order to minimize
scoring  images variation. Data were based on 150 cells for each test or control that
were visually scored as belonging to one of ﬁve classes, according to tail size and
intensity. Classes 0, 1, 2, 3, or 4 were given, with 0 = no detectable damage and
4  = maximum damage. The damage index was  obtained by the formula, damage
index = (0 × n0) + (1 × n1) + (2 × n2) + (3 × n3) + (4 × n4). The variables n0–n4 repre-
sent  the number of nucleoids with 0–4 damage level, and each experiment was
performed  in triplicate.
2.6.  Cellular uptake
The AuNps cellular uptake was investigated using ﬂow cytometry (Suzuki et al.,
2007). In 6-weel cell culture plates, 1 × 106 cells/well were seeded and cultured for
24 h for attach (HepG2) or stabilization (PBMC), treated with 1.0 and 50.0 M AuNps-
PAMAM and AuNps-citrate concentrations at 37 ◦C in a 5% CO2 atmosphere for 24 h.
Cells were then harvested, washed and resuspended in PBS. The uptake of AuNps
was  analyzed by ﬂow cytometer (FACSCalibur, BD BioSciences, San Jose, USA).
2.7. ROS intracellular generation
Intracellular generation of ROS was determined using oxidation of 2′ ,7′-
dichlorodihydroﬂuorescein diacetate (H2DCFDA, Sigma–Aldrich, USA) as previously
described by Sohaebuddin et al. (2010). A DCFH-DA assay was performed for
untreated cells (negative control) and compared to HepG2 cells and PBMC treated
with AuNps-citrate and AuNps-PAMAM, both at 1.0 and 50.0 M concentrations.
A  positive control with hydrogen peroxide was included. After 24 h of exposure to
AuNps, the cells were incubated in the presence of 10 M of DCFH-DA for 30 min
at 37 ◦C. Nonﬂuorescent DCFH-DA is rapidly oxidized to highly ﬂuorescent 2′ ,7′-
dichlorodihydroﬂuorescein (DCF) by ROS. Fluorescence from oxidized DCF was
determined by FACSCalibur® ﬂow cytometer equipped with a 488 nm laser. Data
were taken from 10,000 cells per sample.
2.8.  Statistical analysis
All  experiments were carried out in triplicate, and the results were expressed as
mean ± standard deviation of three independent experiments. Data were evaluated
by  one-way analysis of variance (ANOVA) followed by post hoc Tukey’s Multiple
Comparison  Test, using Graph Pad Prism program software version 5. The results
were  considered statistically signiﬁcant when p < 0.05.
3. ResultsThe typical TEM images and size distribution of the nanoparti-
cles are shown in Fig. 1(a) for AuNps-PAMAM and (b) AuNps-citrate.
The average diameter of AuNps-PAMAM and AuNps-citrate were
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Fig. 2. (a) Percentage of living HepG2 cells after 24 h-incubation with AuNps-Citrate. Data are reported as means ± standard deviation (SD). *Statistically different from the
negative control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). #Statistically different from the positive control group (ANOVA, Tukey’s Multiple Comparison
Test, p < 0.05). (b) Percentage of living HepG2 cells after 24 h-incubation with AuNps-PAMAM. Data are reported as means ± standard deviation (SD). *Statistically different
from the negative control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). #,##,### and ####Statistically different between PAMAM/AuNp 0.01, 0.1, 0.5, 1.0 M
group, respectively, vs. 50.0 M group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). (c) Percentage of living PBMC after 24 h-incubation with AuNps-citrate. Data
are  reported as means ± standard deviation (SD). *Statistically different from the negative control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). #Statistically
different from the positive control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). ##Statistically different between Citrate/AuNp 0.01 M group vs. 1.0 M group
(ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). ###Statistically different between Citrate/AuNp 0.01 M group vs. 50.0 M group (ANOVA, Tukey’s Multiple Comparison
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dest, p < 0.05). (d) Percentage of living PBMC after 24 h-incubation with AuNps-PAMA
egative  control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). #Stati
est, p < 0.05).
stimated using dynamic light scattering (DLS) analysis. Zeta
otential and hydrodynamic diameter were measured before and
fter AuNps dilution into cell culture medium supplemented with
erum (10% FBS) (Table 1).
After incubation of HepG2 cells and PBMC with AuNps-citrate
nd AuNps-PAMAM at concentrations from 0.01 to 50.0 M for
4 h, cell viability was determined by MTT  assay. As shown in Fig. 2,
he viability of HepG2 cells (Fig. 2(a), AuNps-citrate and Fig. 2(b),
uNps-PAMAM) and PBMC (Fig. 2(c), AuNps-citrate and Fig. 2(d),
uNps-PAMAM) decreased signiﬁcantly when compared to nega-
ive control (p < 0.05), except at 0.01 M for AuNps-citrate to both
ells. At the highest concentration (50.0 M),  we observed a sub-
tantial viability reduction in HepG2 cells and PBMC, both with
espect to the negative control.To investigate the DNA damage caused by both types of AuNps,
he comet assay was performed upon incubation of the cells with
.0 and 50.0 M of citrate- and PAMAM-capped Nps. Tables 2 and 3
epict the extensive damage to DNA after treatment of HepG2 andta are reported as means ± standard deviation (SD). *Statistically different from the
y different from the positive control group (ANOVA, Tukey’s Multiple Comparison
PBMC cells, respectively, with both AuNps. The damage index for
AuNps-citrate at 50.0 M and AuNps-PAMAM at 1.0 and 50.0 M
in HepG2 cells were statistically signiﬁcant (p < 0.05), whereas
AuNps-citrate at 1.0 M did not show a signiﬁcant effect (p > 0.05).
Furthermore, the damage index for AuNps-citrate and AuNps-
PAMAM at 1.0 M did not show a signiﬁcant effect (p > 0.05) for
PBMC. At a concentration of 50.0 M,  the AuNps-PAMAM induced
a signiﬁcant toxic effect (p < 0.05) on PBMC cells, compared to the
negative control.
ROS  and reactive nitrogen species (RNS) are generated dur-
ing the inﬂammatory response, especially by phagocytes, and they
may  contribute to the pathology of many inﬂammatory conditions
(Paino et al., 2011). Furthermore, they represent a disturbance in
the balance between pro-oxidant/antioxidant reactions. AuNps cel-
lular uptake were acquired by ﬂow cytometry and appear in Table 4
as a function of side scatter (SSC), representing the cell granularity,
and forward scatter (FSC), representing the cell size. A signiﬁcant
increase in the SSC values was  observed for HepG2 cells only for
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Table  2
DNA  damage index obtained by comet visual score in HepG2 cells pretreated with Citrate coated AuNps or PAMAM coated AuNps and the negative control.
Treatments (M) Comet Classes Damage index ± SD Frequency (%)
0 1 2 3 4
Negative control 96 30 12 9 3 31 ± 11.35 36.0
AuNps-citrate (1) 66 49 19 3 0 32 ± 3.60 47.3
AuNps-citrate (50) 50 57 30 13 0 52 ± 6.24*,# 66.6
AuNp-PAMAM (1) 55 33 35 26  1 61.6 ± 5.03 * 63.3
AuNp-PAMAM (50) 50 34 31 30 5 68.6 ± 10.9* 66.6
Data are reported as means ± standard deviation (SD) of triplicate experiments. One hundred ﬁfty nucleoids were analyzed per treatment in HepG2 cells.
* Statistically different from the negative control without AuNps (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05).
# Statistically different between Citrate/AuNp 1.0 M group vs. Citrate/AuNp 50.0 M group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05).
Table 3
DNA  damage index obtained by comet visual score in PBMC pretreated with Citrate coated AuNps or PAMAM coated AuNps and the negative control.
Treatments (M) Comet Classes Damage index ± SD Frequency (%)
0 1 2 3 4
Negative control 94 35 17 4 0 25.3 ± 3.5 37.3
AuNps-citrate (1) 63 45 23 27 2 50.0 ± 7.0 64.6
AuNps-citrate (50) 60 54 19 12 5 49.3 ± 27.5 60.0
AuNp-PAMAM (1) 60 33 24 4 0  51.3 ± 14.8 40.6
AuNp-PAMAM (50) 45 25 14 21 6 52.0 ± 13.1* 44.0
Data are reported as means ± standard deviation (SD) of triplicate experiments. One hundred ﬁfty nucleoids were analyzed per treatment in PBMC.
* Statistically different from the negative control without AuNps (ANOVA, Tukey’s Multiple Comparison Test p < 0.05).
Table  4
HepG2 and PBMC cellular uptake by AuNps-Citrate and AuNps-PAMAM after 24 h exposure using ﬂow cytometry.
Treatments (M) HepG2 cells PBMC
%FSC %SSC %FSC %SSC
Negative control 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0
AuNps-citrate (1) 99.2 ± 0.5 109.0 ± 3.3 102.1 ± 1.1 104.6 ± 3.0
AuNps-citrate (50) 100.7 ± 1.8 105.1 ± 4.1 98.45 ± 0.8 115.7 ± 3.9*
AuNp-PAMAM (1) 91.3 ± 2.0 96.8 ± 3.0 98.34 ± 0.5 128.4 ± 4.1*
AuNp-PAMAM (50) 85.28 ± 7.8 126.0 ± 0.3*,# 98.46 ± 1.8 135.3 ± 2.1*
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* Statistically different from the negative control without AuNps (ANOVA, Tukey
# Statistically different between PAMAM/AuNp 1.0 M group vs. PAMAM/AuNp 5
uNps-PAMAM treated cells, at a concentration of 50.0 M.  On the
ther hand, PBMC incubated with citrate- and PAMAM-covered
uNps exhibited an increase (p < 0.05) in the SSC values for both
oncentrations investigated from the negative control, except at
.0 M AuNps-citrate. A statistically signiﬁcant (p < 0.05) measure-
ent of intracellular ROS was observed for both HepG2 and PBMC
pon treatment with AuNps, as shown in Fig. 3a and b, respec-
ively.
ig. 3. (a) Effect of AuNp-citrate and AuNp-PAMAM on the generation of ROS in HepG2
eported as means ± standard deviation (SD). *Statistically different from the negative 
uNp-citrate and AuNp-PAMAM on the generation of ROS in PBMC. The %ROS generation 
eviation (SD). *Statistically different from the negative control group (ANOVA, Tukey’s M
roup  (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05).tiple Comparison Test, p < 0.05).
M group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05).
4. Discussion
Data from zeta potential analysis, as depicted in Table 1, sug-
gests that cell culture media containing 10% FBS serum inﬂuences
the nanoparticles stability. Since the medium contains a variety of
salts, amino acids and vitamins, its high ionic strength decrease
the electrostatic repulsive forces among the nanoparticles, induc-
ing aggregation (Fatisson, 2012). On the other hand, proteins from
 cells. The %ROS generation of negative control was considered as 100%. Data are
control group (ANOVA, Tukey’s Multiple Comparison Test, p < 0.05). (b) Effect of
of negative control was considered as 100%. Data are reported as means ± standard
ultiple Comparison Test, p < 0.05). #Statistically different from the positive control
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erum in the medium can adsorb on the nanoparticles creating
 protein “corona”, resulting in the stabilization of the colloidal
uspensions and preventing aggregation upon modifying their
eta potential (Fatisson, 2012; Chithrani et al., 2006), as observed
ere via DLS or hydrodynamic diameter (Table 1). The interac-
ion between the cells and the nanoparticles could be mediated
y nonspeciﬁc adsorption of serum proteins onto the gold surface,
s proposed by Chithrani et al. (2006). In our case, the AuNp uptake
echanism may  occur via receptor-mediated endocytic pathways
clathrin mediated), in agreement to what has been reported by
ativo et al. (2008).
Data  from literature regarding the cytotoxicity and genotoxicity
f citrate or PAMAM-coated AuNps are somehow conﬂicting (Patra
t al., 2007; Pan et al., 2009). The controversy comes from the vari-
bility of parameters, including cell lines used in toxicity assays,
oncentrations, surface charge and coatings. For example, Connor
t al. (2005) demonstrated non-toxic effects of Au nanospheres
diameter from 4 to 18 nm,  covered with citrate, cysteine, glu-
ose, biotin, and cetyltrimethylammonium bromide) on human
eukemia cell line (K562) cells. On the other hand, Patra et al.
2007) reported that 13 nm citrate-coated AuNps exhibited toxicity
gainst a human carcinoma lung cell line, at equal concentrations
rom 20 nM to 120 nM.  As revealed here via cytotoxicity assays,
oth PAMAM-coated and citrate-coated AuNps induced cytotox-
city in HepG2 cells or PBMC. A decrease in cell viability upon
ncubation with AuNps-citrate and AuNps-PAMAM for both HepG2
nd PBMC has been observed using the MTT  assay. A change in mor-
hology of HepG2 cells upon AuNps treatment also indicated the
oxicity effects (data not shown).
The genotoxicity assays employed here, as shown in Table 2
HepG2 cells) and Table 3 (PBMC), can be related to the nanometric
imensions of AuNps, which may  undergo cell uptake (Lewinski
t al., 2008). It was evidenced that AuNps-PAMAM and AuNps-
itrate induced DNA damage, as an indicative of genotoxicity. This
ffect is related to the cellular toxicity of gold nanoparticles, which
n our case is also related to the small size of the particles that
asily undergo cell uptake through diffusion, in agreement with
ernodet et al. (2006). Li et al. (2008) demonstrated that serum
oated 20 nm AuNps were also able to induce genotoxicity in the
orm of single-strand lesions in DNA in human lung ﬁbroblasts.
ur analyses provided convincing evidence of the toxic effect of
uNps, indicating that surface charge or size may  be a major deter-
inant of how AuNps impact cellular processes. Furthermore, the
NA damage index for AuNps-PAMAM and AuNps-Citrate was sta-
istically signiﬁcant analyzed for HepG2 cells, except at 1.0 M
uNps-Citrate. The genotoxicity for PBMC was statistically signif-
cant only upon incubation with AuNps-PAMAM at 50.0 M.  The
endency of the AuNps to accumulate in the cells nuclei was  associ-
ted with their small size, which allows the nanoparticles to freely
iffuse through pore complex (Zhao and Nalwa, 2007). Since the
omet assay evaluates the reversible DNA damage, our genotoxic-
ty results also suggest that PBMC, a primary cell culture, were less
ensitive to DNA damage to a certain extent the nanoparticles than
epG2 cancer cells. The purpose was to analyze the repair system
n comet assay evidencing the DNA repair.
The use of SSC parameter obtained via ﬂow cytometry has been
roposed as an efﬁcient way to investigate cell uptake (Suzuki
t al., 2007). In our analyses, the uptake of both types of AuNps
as monitored by SSC (Table 4), revealing that for HepG2 cells,
he relative SSC values were signiﬁcantly increased (p < 0.05) only
or cells incubated with AuNps-PAMAM at 50.0 M.  In contrast,
he PBMC exhibited an increase in the SSC values for cells incu-
ated with both types of nanoparticles at 50.0 M.  Furthermore,
 signiﬁcantly increase in SSC was also observed for PBMC upon
ncubation with AuNps-PAMAM at the lower concentration inves-
igated (1.0 M).tters 215 (2012) 119– 125
The  generation of ROS represents an important mechanism in
the toxicity induced by AuNps, which may disturb the equilib-
rium between antioxidant and oxidant intracellular processes. The
ROS generation was evidenced here for HepG2 cells and PBMC
incubated with both types of nanoparticles for 24 h, as shown in
Fig. 3a and b, respectively. For both PBMC and HepG2 cells, a signif-
icant increase in the ROS generation was  observed upon incubation
with citrate and PAMAM-covered AuNps (Fig. 3a and b). The cel-
lular oxidative stress increased in both cell lines may  be directly
correlated with AuNps exposure, homologous to an increase in
cytotoxicity.
5. Conclusion
Taken together, our ﬁndings suggest that the exposure of HepG2
cells and PBMC to AuNps-PAMAM and AuNps-citrate might lead to
the disturbance of cells with cytotoxic effects and DNA damage. The
correlation between the toxic effects of Au nanoparticles with their
physico-chemical and surface properties may  be an important step
forward to the application of these nanomaterials in cancer treat-
ment. Our results from the comet assay, for example, revealed that
the immune system cells (PBMC) were less sensitive to DNA dam-
age than cancer HepG2 cells, upon exposure to AuNps. The latter is
an indicative that nanoparticulate systems may  be applied in cancer
therapy with reduced side effects in the future studies.
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